öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÂ¬¹ú¶°
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º480

ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧ
ËùÊôԺϵ£º¹«¹²ÎÀÉúѧԺ¡¢¹ú¼ÒÉúÎï°ÐÏòÕïÖιú¼ÊÁªºÏÖÐÐÄ¡¢»ù´¡Ò½Ñ§Ôº
Ö°³Æ£ºÑо¿Ô±
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÎÀÉú¶¾Àíѧ¡¢Ò½Ñ§ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ¡¢Ò½Ñ§ÉúÀíѧ
Ñо¿ÁìÓò£º ¸Î°©µÄ·Ö×ÓÉúÎïѧºÍת»¯Ò½Ñ§Ñо¿,·Ö×Ó¶¾Àíѧ
Ñо¿ÁìÓò£º ¸Î°©µÄ·Ö×ÓÉúÎïѧºÍת»¯Ò½Ñ§Ñо¿,·Ö×Ó¶¾Àíѧ [ÊÕÆð]




¸öÈ˼òÊö :
¬¹ú¶°½ü5ÄêÖ÷ÒªÑо¿Ö¬·¾´úл¶Ô¸Îϸ°û°©·¢²¡ºÍ·¢Õ¹µÄ×÷Óã¬Í¨¹ýÁÙ´²Á÷Ðв¡Ñ§¡¢¶¯ÎïÄ£ÐͺͷÖ×Ó»úÖÆÑо¿£¬½ÒʾÁË»ùÒòC/EBPalpha¼ÈÊÇÖ¬·¾ºÏ³É´úлµÄ¹Ø¼üת¼Òò×Ó£¬ÓÖÔÚ´úлÐÔÓ¦¼¤Ï´ٽø×ÔÊɺÍÖ¬·¾·Ö½â´úл´Ó¶ø±£»¤¸Î°©Ï¸°ûÃâÓÚËÀÍö£»C/EBPalphaÔڸΰ©×éÖ¯µÄ±í´ïÓë¸Î°©»¼ÕߵIJ»Á¼Ô¤ºóÏÔÖøÕýÏà¹Ø£¬Í¬Ê±¾ö¶¨ÁËÂãÊó¸Î°©ÒÆÖ²ÁöµÄ´æ»îºÍ·¢Õ¹¡£Ñо¿³É¹û·¢±íÔÚ賦¸Î²¡Ñ§ÅÅÃûµÚһλµÄGastroenterology£¨2010Ä꣬µÚÒ»×÷Õߣ¬IF£º18.187£©ºÍµÚÈýµÄHepatology£¨2015Ä꣬µÚÒ»×÷Õߺ͹²Í¬Í¨Ñ¶×÷Õߣ¬IF£º11.711£©¡£ÕâЩÑо¿ÎªÍ¨¹ý×è¶Ï×ÔÊɺÍÖ¬·¾´úлÀ´´Ù½ø¸Î°©Ï¸°ûËÀÍöºÍÖÎÁƸΰ©ÌṩÁËÖØÒªµÄÀíÂÛÒÀ¾ÝºÍ°ÐÏòλµã¡£Ñо¿½ÒʾÁËC/EBPalpha-×ÔÊÉ-Ö¬·¾·Ö½â´úлͨ·¶ÔÓڸΰ©ÖÎÁƵİÐÏò×÷Ó㬿ÉÒÔºÍÏÖÓеĸζ¯Âö˨ÈûÖÎÁƽáºÏ£¬¾ßÓÐÁ¼ºÃµÄת»¯Ó¦ÓÃÇ°¾°¡£Â¬¹ú¶°Ñ§Ï°ºÍ¹¤×÷Æڼ乲·¢±íSCIÂÛÎÄ14ƪ£¬½üÎåÄê·¢±íSCIÂÛÎÄ9ƪ£¬²Î±àÓ¢ÎÄÂÛÖø1²¿ºÍÖÐÎÄÈËÃñÎÀÉú°æ½Ì²Ä3²¿¡£µ¥ÆªÂÛÎı»ÒýÓÃ×î¸ß217´Î£¬×ÜÒýÓÃ341´Î¡£¶à´Î±»ÑûÇëÔÚ¹ú¼Ê¿ÆÑдó»áÉÏ×öÑݽ²¼Î±ö±¨¸æ£¨2016ÄêÓ¡ÄáÈÕÈÇ£¬2015ÄêÖйúÄϾ©£¬2010Ä꺫¹ú¸ªÉ½£©¡£Ä¿Ç°Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿1Ï¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð»Ø¹úÖصãÏîÄ¿1ÏÌØƸ½ÌÊÚÆô¶¯»ù½ð1ÏÈëÑ¡¹ãÎ÷½ÌÓýÌü2016Äê¸ßУÒý½øº£Íâ¸ß²ã´ÎÈ˲š°°ÙÈ˼ƻ®¡±ºÍ¹ãÎ÷Ò½¿Æ´óѧ¡°½Ü³öÇàÄêÅàÑø¼Æ»®¡±£»ÔøÖ÷³ÖмÓƹúÁ¢´óѧSwee-Liew?Wadsworth?Research?Memorial?Fund?Concept?Grant»ù½ð1Ï×÷Ϊ¸ºÔðÈ˹²»ñµÃÑо¿¾­·Ñ385ÍòÔª¡£²¢×÷ΪÖ÷ÒªÑо¿ÈËÔ±²ÎÓë3ÏîмÓÆÂÎÀÉú²¿»ò½ÌÓý²¿¿ÎÌ⣨ÀÛ¼Æ91ÍòмÓÆÂÔª£©¡£ÈëÖ°ÒÔÀ´£¬»ñµÃ¹ãÎ÷Ò½¿Æ´óѧ2015Äê¶ÈµÄУ¼¶ÓÅÐã½Ìʦ£¬2015Äê¶ÈºÍ2016Äê¶ÈµÄ×îÊÜ»¶Ó­È«Ó¢½Ìʦ£¬»ñµÃ¹ãÎ÷Ò½¿Æ´óѧ2016Äê¶È½ÌÓý½Ìѧ¸Ä¸ïÖصã×ÊÖúÏîÄ¿1Ïî¡£ÕýÔڲαàÈËÃñÎÀÉú³ö°æÉç½Ì²Ä4²¿¡£

¿ÆÑй¤×÷ :
Ö÷ÒªÑо¿³É¹û£ºÖ×ÁöѧÑо¿1. Zhou?J?*,?Tang?Y?*,?Xie?ZJ?*,?Lu?JN?*,?Deng?JH,?Huang?XW,?Chuan?Hooi?S,?He?M?#,?Lu?GD?#.?AKT?activation?was?not?essential?for?hepatocellular?carcinoma?cell?survival?under?glucose?deprivation.?Anticancer?Drugs.?2017?Apr28(4):427-435.?(¹²Í¬Í¨Ñ¶×÷Õߣ¬IF:?2.268)?)?(ÖпÆԺҽѧ4Çø)2. Liu?GF?*?Lv?JY?*?Zhang?YJ?*?Zhang?LX?Lu?GD?Xie?ZJ?Cheng?MB?Shen?YF?Zhang?Y?#.?C/EBPalpha?negatively?regulates?SIRT7?expression?via?recruiting?HDAC3?to?its?upstream-promoter?in?hepatocellular?carcinoma?cells.?Biochimica?et?Biophysica?Acta-Gene?Regulatory?Mechanisms.?2016?1859:348-354?(IF:?5.373£¬±»ÒýÓãº1)3. Ler?SY?*,?Leung?CH?*,?Khin?LW,?Lu?GD,?Salto-Tellez?M,?Hartman?M,?Lau?PT,?Yap?CT?#,?Hooi?SC?#.?HDAC1?and?HDAC2?independently?predict?mortality?in?hepatocellular?carcinoma?by?a?competing?risk?in?regression?model?in?a?Southeast?Asian?population.?Oncology?Reports.?2015?Sep?34:?2238-2250.?(2015?IF:?2.486)?(ÖпÆԺҽѧ3Çø£¬±»ÒýÓãº5)4. Lu?GD?*?#,?Ang?YH,?Zhou?J,?Tamilarasi?J,?Yan?B,?Lim?YC,?Srivastava?S,?Salto-Tellez?M,?Hui?KM,?Shen?HM,?Nguyen?LN,?Tan?BC,?Silver?DL,?Hooi?SC?#.?CCAAT/enhancer?binding?protein?¦Á?predicts?poorer?prognosis?and?prevents?energy?starvation¨Cinduced?cell?death?in?hepatocellular?carcinoma.?Hepatology.?2015?Mar61(3):965-78.?£¨µÚÒ»×÷Õߺ͹²Í¬Í¨Ñ¶×÷Õß,?2015?IF:?11.711£©(ÖпÆԺҽѧ1Çø£¬±»ÒýÓãº9)5. Huang?BH,?Zhuo?JL,?Leung?CH,?Lu?GD,?Liu?JJ,?Yap?CT?#,?Hooi?SC?#.?PRAP1?is?a?novel?executor?of?p53-dependent?mechanisms?in?cell?survival?after?DNA?damage.?Cell?Death?&?Disease.?2012?Dec?133:e442.?(IF:5.378?2012IF:?6.044)?(ÖпÆÔºÉúÎï2Çø£¬±»ÒýÓãº9)?6. Lu?GD,?Leung?CH,?Yan?B,?Tan?CM,?Low?SY,?Aung?MO,?Salto-Tellez?M,?Lim?SG,?Hooi?SC?#.?C/EBPalpha?is?up-regulated?in?a?subset?of?hepatocellular?carcinomas?and?plays?a?role?in?cell?growth?and?proliferation.?Gastroenterology.?2010?Aug139(2):632-43.?(IF:?18.187?2010?IF:?12.032)?(ÖпÆԺҽѧ1Çø£¬±»ÒýÓãº16)?7. Zhou?J,?Lu?GD,?Ong?CS,?Ong?CN,?Shen?HM?#.?Andrographolide?sensitizes?cancer?cells?to?TRAIL-induced?apoptosis?via?p53-mediated?death?receptor?4?up-regulation.?Molecular?Cancer?Therapeutics.?2008?Jul7(7):2170-80.(IF:5.579?2008?IF:?5.003)?(ÖпÆԺҽѧ2Çø£¬±»ÒýÓãº58)?8. Lu?GD,?Shen?HM,?Chung?MC,?Ong?CN?#.?Critical?Role?of?Oxidative?Stress?and?Sustained?JNK?Activation?in?Aloe-Emodin-Mediated?Apoptotic?Cell?Death?in?Human?Hepatoma?Cells.?Carcinogenesis.?2007?Sep28(9):1937-45.(IF:?4.874?2007?IF:?5.406)?(ÖпÆԺҽѧ2Çø£¬±»ÒýÓãº35)?